Using a synthetic heparinoid, danaparoid (Orgaran), in two cardiopulmonary bypass procedures in a same patient with heparin-induced thrombocytopenia;Utilisation de l'Orgaran, héparinoïde de synthèse, lors de deux circulations extracorporelles, chez un même patient allergique à l'héparine

Archives des Maladies du Coeur et des Vaisseaux

Volumn 94, Issue 2, 2001, Pages 144-147

  Pineau, E ^a   Le Bret, E ^a   Folliguet, T ^a   Saint Maurice, O ^a   Carbognani, D ^a   Laborde, F ^a  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; DANAPAROID; HEPARIN; HEPARINOID; PROTAMINE;

ADULT; ARTICLE; BLEEDING; CARDIOPULMONARY BYPASS; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; ENDOCARDITIS; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; PREOPERATIVE CARE; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; CARDIOPULMONARY BYPASS; CHONDROITIN SULFATES; CORONARY ARTERY BYPASS; DERMATAN SULFATE; ENDOCARDITIS; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEPARIN; HEPARIN ANTAGONISTS; HEPARITIN SULFATE; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; PROSTHESIS FAILURE; PROTAMINES; REOPERATION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0035114967     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin and unfractionated heparin
2. Thrombopénies induites par l'héparine. Diagnostic et conduite thérapeutique
3. " Heparin-free " cardiopulmonary bypass: First reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass
4. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172
5. Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia
6. Intraoperative monitoring of danaparoid sodium anticoagulation during cardiovascular operations
7. Thrombopénies majeures induites par I'héparine. Attitude pratique en chirurgie cardiaque sous CEC
8. Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with Orgaran (Org 10172)
9. Collaborative overview of randomised trials of antiplatelet therapy-II: Maintenance of vascular graft or arterial patency by antiplatelet therapy
10. Heparin-induced thrombocytopenia type II: Perioperative management using danaparoid in a coronary artery bypass patient with renal failure
11. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia